Stem Cells May Move to the Front Line against Multiple Sclerosis

Researchers maintain that patients with severe multiple sclerosis should be able to receive autologous hematopoietic stem cell transplantation as a first-line therapy.

Related Keywords

Italy ,Sweden ,Milan ,Lombardia ,Ositran ,Veneto ,United Kingdom ,London ,City Of ,Uppsala ,Uppsala Lan ,Gavin Giovannoni ,John Snowden ,Basil Sharrack ,Dame Pamela Shaw ,Raffaella Greco ,Joachim Burman ,Richard Burt ,Uppsala University ,Sclerosis International Stem Cell ,London School Of Medicine ,Department Of Medical Sciences ,University Of Sheffield ,European Society For Blood ,Uk National Institute For Health ,Autoimmune Diseases Working Party ,Sheffield Institute For Translational Neuroscience Sitra ,Care Research ,Imperial College London Paoloa Muraro ,Ms Research Clinic ,Northwestern University ,Sheffield Institute ,Translational Neuroscience ,Third International Symposium ,Stem Cell Treatment ,Multiple Sclerosis ,Marrow Transplant ,Raffaele Hospital ,European Society ,Marrow Transplantation ,Sheffield Teaching Hospitals ,Treatment Algorithm ,Multiple Sclerosis Disease Modifying ,London School ,Imperial College London ,Medical Sciences ,Experimental Neurology ,Expanded Disability Status Scale ,Autologous Stem Cell Transplantation ,Relapsing Remitting Multiple Sclerosis ,